Recall Record

Memphis, TN, United States

McKesson Corporation dba McKesson Drug Company recalls

2 recalls recorded since 2018, most recently on 21 April 2022. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls2
Ongoing (FDA)1
Terminated or completed1
Class I (FDA)0

Ongoing Class II Drugs

Recall started
21 April 2022
Reason
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
Distribution
Nationwide in the United States including Guam and the Northern Mariana Islands.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0848-2022, D-0851-2022, D-0847-2022, D-0849-2022, D-0850-2022

Terminated Class III Drugs

Recall started
26 May 2021
Terminated
29 September 2022
Reason
Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam
Distribution
Nationwide in the US
Initiated
Voluntary: Firm initiated
Recall number
D-0630-2021

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.